Module based antibody engineering: A novel synthetic REDantibody

Journal of Immunological Methods

Volumn 364, Issue 1-2, 2011, Pages 40-49

  Markiv, Anatoliy ^a   Anani, Bernard ^a   Durvasula, Ravi V ^b   Kang, Angray S ^a  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Antibody engineering; Fluorescent proteins; ScFv; Synthetic antibody

Indexed keywords

IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 4D5 8; MONOCLONAL ANTIBODY B.72.3; PROTEIN P185; RED ANTIBODY; RED FLUORESCENT PROTEIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIBODY COMBINING SITE; ANTIBODY ENGINEERING; ANTIBODY SCREENING; ARTICLE; BINDING AFFINITY; BLOOD GROUP LEWIS SYSTEM; CARBOXY TERMINAL SEQUENCE; DISULFIDE BOND; ESCHERICHIA COLI; IMMUNOFLUORESCENCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; X RAY CRYSTALLOGRAPHY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CRYSTALLOGRAPHY, X-RAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LUMINESCENT PROTEINS; MODELS, CHEMICAL; PROTEIN CONFORMATION; PROTEIN ENGINEERING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; STEREOISOMERISM;

ESCHERICHIA COLI; TRYPANOSOMA CRUZI;

EID: 78650823997     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2010.10.009     Document Type: Article

References (37)

1. Arndt K.M., Muller K.M., Pluckthun A. Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment. Biochemistry 1998, 37:12918-12926.
2. Barry G.T., Goebel W.F. Colominic acid, a substance of bacterial origin related to sialic acid. Nature 1957, 179:206.
3. Bazl M.R., Rasaee M.J., Foruzandeh M., Rahimpour A., Kiani J., Rahbarizadeh F., Alirezapour B., Mohammadi M. Production of chimeric recombinant single domain antibody-green fluorescent fusion protein in Chinese hamster ovary cells. Hybridoma (Larchmt) 2007, 26:1-9.
4. Bertani G. Lysogeny at mid-twentieth century: P1, P2, and other experimental systems. J. Bacteriol. 2004, 186:595-600.
5. Betta P.G., Pavesi M., Pastormerlo M., Tallarida F., Bellingeri D., Bocca R. Use of monoclonal antibody B72.3 as a marker of metastatic carcinoma cells in neoplastic effusions. Pathologica 1991, 83:99-104.
6. Bird R.E., Hardman K.D., Jacobson J.W., Johnson S., Kaufman B.M., Lee S.M., Lee T., Pope S.H., Riordan G.S., Whitlow M. Single-chain antigen-binding proteins. Science 1988, 242:423-426.
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
8. Brady R.L., Hubbard R.E., King D.J., Low D.C., Roberts S.M., Todd R.J. Crystallization and preliminary X-ray diffraction study of a chimaeric Fab' fragment of antibody binding tumour cells. J. Mol. Biol. 1991, 219:603-604.
9. Campbell R.E., Tour O., Palmer A.E., Steinbach P.A., Baird G.S., Zacharias D.A., Tsien R.Y. A monomeric red fluorescent protein. Proc. Natl Acad. Sci. USA 2002, 99:7877-7882.
10. Casey J.L., Coley A.M., Tilley L.M., Foley M. Green fluorescent antibodies: novel in vitro tools. Protein Eng. 2000, 13:445-452.
11. Eigenbrot C., Randal M., Presta L., Carter P., Kossiakoff A.A. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling. J. Mol. Biol. 1993, 229:969-995.
12. Freire T., Robello C., Soule S., Ferreira F., Osinaga E. Sialyl-Tn antigen expression and O-linked GalNAc-Thr synthesis by Trypanosoma cruzi. Biochem. Biophys. Res. Commun. 2003, 312:1309-1316.
13. Griep R.A., van Twisk C., van der Wolf J.M., Schots A. Fluobodies: green fluorescent single-chain Fv fusion proteins. J. Immunol. Methods 1999, 230:121-130.
14. Hink M.A., Griep R.A., Borst J.W., van Hoek A., Eppink M.H., Schots A., Visser A.J. Structural dynamics of green fluorescent protein alone and fused with a single chain Fv protein. J. Biol. Chem. 2000, 275:17556-17560.
15. Holliger P., Prospero T., Winter G. "Diabodies": small bivalent and bispecific antibody fragments. Proc. Natl Acad. Sci. USA 1993, 90:6444-6448.
16. Huston J.S., Levinson D., Mudgett-Hunter M., Tai M.S., Novotny J., Margolies M.N., Ridge R.J., Bruccoleri R.E., Haber E., Crea R., et al. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl Acad. Sci. USA 1988, 85:5879-5883.
17. Khrameeva E.E., Drutsa V.L., Vrzheshch E.P., Dmitrienko D.V., Vrzheshch P.V. Mutants of monomeric red fluorescent protein mRFP1 at residue 66: structure modeling by molecular dynamics and search for correlations with spectral properties. Biochemistry (Mosc) 2008, 73:1085-1095.
18. Koprowski H., Steplewski Z., Mitchell K., Herlyn M., Herlyn D., Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet. 1979, 5:957-971.
19. Lerner R.A. Manufacturing immunity to disease in a test tube: the magic bullet realized. Angew. Chem. Int. Ed Engl. 2006, 45:8106-8125.
20. Morino K., Katsumi H., Akahori Y., Iba Y., Shinohara M., Ukai Y., Kohara Y., Kurosawa Y. Antibody fusions with fluorescent proteins: a versatile reagent for profiling protein expression. J. Immunol. Methods 2001, 257:175-184.
21. Olichon A., Surrey T. Selection of genetically encoded fluorescent single domain antibodies engineered for efficient expression in Escherichia coli. J. Biol. Chem. 2007, 282:36314-36320.
22. Pant K.D., Jain A., McCracken J.D., Thompson K. Immunohistochemical examination of anti-STn monoclonal antibodies LLU9B4, B72.3, and B35.2 for their potential use as tumor markers. Dig. Dis. Sci. 2008, 53:2189-2194.
23. Pavoor T.V., Cho Y.K., Shusta E.V. Development of GFP-based biosensors possessing the binding properties of antibodies. Proc. Natl Acad. Sci. USA 2009, 106:11895-11900.
24. Peipp M., Saul D., Barbin K., Bruenke J., Zunino S.J., Niederweis M., Fey G.H. Efficient eukaryotic expression of fluorescent scFv fusion proteins directed against CD antigens for FACS applications. J. Immunol. Methods 2004, 285:265-280.
25. Reddish M.A., Jackson L., Koganty R.R., Qiu D., Hong W., Longenecker B.M. Specificities of anti-sialyl-Tn and anti-Tn monoclonal antibodies generated using novel clustered synthetic glycopeptide epitopes. Glycoconj. J. 1997, 14:549-560.
26. Schwalbach G., Sibler A.P., Choulier L., Deryckere F., Weiss E. Production of fluorescent single-chain antibody fragments in Escherichia coli. Protein Expr. Purif. 2000, 18:121-132.
27. Serebrovskaya E.O., Edelweiss E.F., Stremovskiy O.A., Lukyanov K.A., Chudakov D.M., Deyev S.M. Targeting cancer cells by using an antireceptor antibody-photosensitizer fusion protein. Proc. Natl Acad. Sci. USA 2009, 106:9221-9225.
28. Shcherbo D., Merzlyak E.M., Chepurnykh T.V., Fradkov A.F., Ermakova G.V., Solovieva E.A., Lukyanov K.A., Bogdanova E.A., Zaraisky A.G., Lukyanov S., Chudakov D.M. Bright far-red fluorescent protein for whole-body imaging. Nat. Methods 2007, 4:741-746.
29. Stepanenko O.V., Verkhusha V.V., Shavlovskii M.M., Aleinikova T.D., Uverskii V.N., Kuznetsova I.M., Turoverov K.K. The role of quarternary structure in fluorescent protein stability. Tsitologiia 2005, 47:1017-1027.
30. Studier F.W. Use of bacteriophage T7 lysozyme to improve an inducible T7 expression system. J. Mol. Biol. 1991, 219:37-44.
31. Troise F., Cafaro V., Giancola C., D'Alessio G., De Lorenzo C. Differential binding of human immunoagents and Herceptin to the ErbB2 receptor. FEBS J. 2008, 275:4967-4979.
32. Tsien R.Y. Constructing and exploiting the fluorescent protein paintbox (Nobel lecture). Angew. Chem. Int. Ed Engl. 2009, 48:5612-5626.
33. Winter G. Synthetic human antibodies and a strategy for protein engineering. FEBS Lett. 1998, 430:92-94.
34. Winter G., Milstein C. Man-made antibodies. Nature 1991, 349:293-299.
35. Worn A., Pluckthun A. An intrinsically stable antibody scFv fragment can tolerate the loss of both disulfide bonds and fold correctly. FEBS Lett. 1998, 427:357-361.
36. Worn A., Pluckthun A. Stability engineering of antibody single-chain Fv fragments. J. Mol. Biol. 2001, 305:989-1010.
37. Yang F., Moss L.G., Phillips G.N. The molecular structure of green fluorescent protein. Nat. Biotechnol. 1996, 14:1246-1251.